CN1076625A - A kind of new drug for the treatment of chronic aplastic anemia - Google Patents
A kind of new drug for the treatment of chronic aplastic anemia Download PDFInfo
- Publication number
- CN1076625A CN1076625A CN 93110457 CN93110457A CN1076625A CN 1076625 A CN1076625 A CN 1076625A CN 93110457 CN93110457 CN 93110457 CN 93110457 A CN93110457 A CN 93110457A CN 1076625 A CN1076625 A CN 1076625A
- Authority
- CN
- China
- Prior art keywords
- aplastic anemia
- spirit
- new drug
- chronic
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of new drug for the treatment of chronic aplastic anemia---aplastic anemia spirit belongs to peptide or proteinic preparation.This pure Chinese medicinal preparation is theoretical with the chronic aplastic anemia differentiation of symptoms and signs for classification of syndrome according to the traditional Chinese medical science " asthenia mass formed by blood stasis ", and two kinds of basis sides are made in the aplastic anemia spirit, i.e. clever I number of aplastic anemia, clever II number of aplastic anemia.The aplastic anemia spirit is a promoting flow of QI and blood I number, stasis-removed new drug, and the aplastic anemia spirit is a warming the kidney to invigorate YANG II number, supplementing primordial qi drug.Aplastic anemia spirit I number, II number can make tablet, pill or powder.This Drug therapy chronic aplastic anemia effective percentage reaches 97%, and cure rate reaches 70%.
Description
A kind of new drug-aplastic anemia spirit for the treatment of chronic aplastic anemia.Belong to peptide or proteinic preparation.
Chronic aplastic anemia is one group of syndrome of hemopoietic function depletion, good sending out studied more in teenager is domestic with the Chinese herbal treatment chronic aplastic anemia, " the aplastic anemia hemopoietic " that Liao Yuan city associate chief physician develops with 21 kinds of Chinese herbal medicine, curative effect reaches 79%(88 and advances the magazine third phase), Ling County, source, Hunan Province and Hunan Province hospital of the Armed Police contingent utilize Chinese herbal treatment aplastic anemia effective percentage to reach more than 70%.In sum, the level with the western medical treatment aplastic anemia is consistent basically for the level of Chinese herbal treatment aplastic anemia at present, and curative effect is not very good.
The purpose of this invention is to provide a kind of treatment aplastic anemia curative effect height, the Chinese herbal medicine that cure rate is high-aplastic anemia spirit.
Solution of the present invention is according to the traditional Chinese medical science " asthenia mass formed by blood stasis " is theoretical the chronic aplastic anemia differentiation of symptoms and signs for classification of syndrome to be made the aplastic anemia spirit two kinds of basis sides simultaneously, i.e. the clever I of aplastic anemia number, the clever II of aplastic anemia number.Aplastic anemia spirit I is number by promoting flow of QI and blood, and the medicine of eliminating blood stasis to promote regeneration of blood is formed, and includes Radix Notoginseng, Pollen Typhae, short ground Mulberry, the Pseudobulbus Bletillae (Rhizoma Bletillae), sharp, the Cornu Saigae Tataricae of pine.Aplastic anemia spirit II number is made up of the medicine of the kidney warming, tonifying YANG, strongly invigorating primordial QI, includes people's Placenta Hominis, Hepar Caprae seu ovis, Embryo cervi, the Radix Astragali, Radix Ginseng.Aplastic anemia I number, aplastic anemia II number make tablet, pill or powder after processing, take after mixing it with water with the white sugar boiled water when taking.
Prescription of the present invention is simple, and with strong points to the aplastic anemia treatment, through 30 routine clinical observations, effective percentage reaches 97%, and cure rate reaches 70%.
Aplastic anemia of the present invention spirit I number, adopt following proportioning, Radix Notoginseng is more than 5%, and Pollen Typhae is more than 10%, and short ground Mulberry is greater than 25%, the Pseudobulbus Bletillae (Rhizoma Bletillae) is greater than 25%, the pine point is more than 5%, and Cornu Saigae Tataricae is greater than 5%, and Pollen Typhae, short ground Mulberry, loose point all need parch to black to grind into powder, Radix Notoginseng, Cornu Saigae Tataricae are directly ground into powder, are aplastic anemia spirit I electuary behind the medicine mix homogeneously of pulverization.The proportioning of aplastic anemia spirit II number is as follows, and people's Placenta Hominis is more than 10%, and Hepar Caprae seu ovis 10% above Embryo cervi more than 5%, the Radix Astragali are more than 50%, the Radix Ginseng joins more than 10%, the Radix Astragali, Radix Ginseng be water boiling concentration in advance, and the reuse concentrated solution decocts people's Placenta Hominis, Hepar Caprae seu ovis, Embryo cervi, dries to grind into powder to be aplastic anemia spirit II electuary.Criterion of therapeutical effect according in July, 1981 Langfang meeting and the 4th the aplastic anemia academic conference revision in June, 1987 whole nation, epistaxis, hematohidrosis, the bleeding from the gum three person of possessing 11 examples in the 30 routine clinical observation objects, epistaxis merges hematohidrosis person 6 examples, bleeding from the gum merges hematohidrosis person 13 examples, oldest 58 years old, minimum 5 years old, male's 18 examples, women's 12 examples, what the state of an illness was the longest is 8 years, the shortest is 3 months, cure 21 examples after taking aplastic anemia spirit I number, aplastic anemia spirit II number, account for 70%, 8 examples take a favorable turn, no change 1 example, the treatment effective percentage reaches 97%.
Claims (3)
1, a kind of new drug-aplastic anemia spirit for the treatment of chronic aplastic anemia, it is characterized in that this medicine has two kinds of basis sides, it is aplastic anemia spirit I number, aplastic anemia spirit II number, aplastic anemia spirit I number is the promoting flow of QI and blood stasis-removed new drug, include Radix Notoginseng, Pollen Typhae, short ground Mulberry, the Pseudobulbus Bletillae (Rhizoma Bletillae), pine point, Cornu Saigae Tataricae, aplastic anemia spirit II number is warming the kidney to invigorate YANG, supplementing primordial qi drug, includes people's Placenta Hominis, Hepar Caprae seu ovis, Embryo cervi, the Radix Astragali, Radix Ginseng.
2, according to a kind of new drug-aplastic anemia spirit for the treatment of chronic aplastic anemia of claim 1, the proportioning that it is characterized in that aplastic anemia spirit I number is that Radix Notoginseng is more than 5%, Pollen Typhae more than 10%, short ground Mulberry are greater than 25%, and the Pseudobulbus Bletillae (Rhizoma Bletillae) is greater than 25%, and the pine point is more than 5%, Cornu Saigae Tataricae is greater than 5%, the proportioning of aplastic anemia spirit II number is people's Placenta Hominis more than 10%, and Hepar Caprae seu ovis is more than 10%, and Embryo cervi is more than 5%, the Radix Astragali is more than 50%, and the Radix Ginseng is more than 10%.
3, according to a kind of new drug-aplastic anemia spirit for the treatment of chronic aplastic anemia of claim 1, it is characterized in that this medicine can be made into tablet, pill or powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93110457 CN1076625A (en) | 1993-02-12 | 1993-02-12 | A kind of new drug for the treatment of chronic aplastic anemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93110457 CN1076625A (en) | 1993-02-12 | 1993-02-12 | A kind of new drug for the treatment of chronic aplastic anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1076625A true CN1076625A (en) | 1993-09-29 |
Family
ID=4988323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93110457 Pending CN1076625A (en) | 1993-02-12 | 1993-02-12 | A kind of new drug for the treatment of chronic aplastic anemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1076625A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056073C (en) * | 1995-03-11 | 2000-09-06 | 高风兰 | Nutritious health-care oral liquor |
| CN1080564C (en) * | 1995-09-15 | 2002-03-13 | 仇殿明 | Medicine for treatment of aplastic anemia and its preparation method |
-
1993
- 1993-02-12 CN CN 93110457 patent/CN1076625A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056073C (en) * | 1995-03-11 | 2000-09-06 | 高风兰 | Nutritious health-care oral liquor |
| CN1080564C (en) * | 1995-09-15 | 2002-03-13 | 仇殿明 | Medicine for treatment of aplastic anemia and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614440B (en) | Multi-herb antibacterial liquid | |
| CN100506251C (en) | Chinese medicine preparation for treating mastoproliferation and preparation method thereof | |
| CN1060350C (en) | Chinese medicine for treatment of woman postpartum disease | |
| CN100336527C (en) | Medicine for treating celevical vertebra disease | |
| CN1313135C (en) | Medicine for treating ulcer | |
| CN101391056B (en) | Medicine for treating aplastic anemia | |
| CN1331501C (en) | Blood-activating stasis-resolving mixture and preparation method thereof | |
| CN100493585C (en) | Pure Chinese traditional medicine for treating chronic pelvic inflammatory disease and menoxenia disease | |
| CN102274417B (en) | Chinese prepared medicament for treating aplastic anemia | |
| CN101455764B (en) | Traditional Chinese medicine for treating zoster | |
| CN101396528A (en) | Traditional Chinese medicine composite preparation for treating wind-heat cold | |
| CN102416145A (en) | Traditional Chinese medicine composition for treating menstrual disorder | |
| CN1076625A (en) | A kind of new drug for the treatment of chronic aplastic anemia | |
| CN1468628A (en) | Medicine for treatnig ovarian cyst | |
| CN101199749A (en) | Chinese medicine for treating AIDS | |
| CN1120943A (en) | Nose opening capsule and its preparation method | |
| CN111084820B (en) | Traditional Chinese medicine composition for treating chronic kidney disease malnutrition and preparation and application thereof | |
| CN1899482A (en) | Medicine for treating chronic glomerular nephritis and its producing method | |
| CN104435545A (en) | Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning | |
| CN104587131A (en) | Traditional Chinese medicinal composition for treating delayed menorrhea | |
| CN115252679B (en) | Traditional Chinese medicine composition for treating ischemic cardiomyopathy and application thereof | |
| CN102038926A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea | |
| CN103055085B (en) | Traditional Chinese medical preparation for treating iron-deficiency anemia | |
| CN113069498A (en) | Radix astragali and radix paeoniae alba goiter eliminating mixture | |
| CN101147759A (en) | Proprietary Chinese medicine for treating leucoderma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |